THR-β agonist 4

Modify Date: 2024-01-15 22:31:08

THR-β agonist 4 Structure
THR-β agonist 4 structure
Common Name THR-β agonist 4
CAS Number 2673409-25-9 Molecular Weight 510.26
Density N/A Boiling Point N/A
Molecular Formula C16H11Cl2F2N5O6S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of THR-β agonist 4


THR-β agonist 4 is a potent agonist of THR-β. THR-β agonist 4 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021143706A1, compound 72)[1].

 Names

Name THR-β agonist 4

 THR-β agonist 4 Biological Activity

Description THR-β agonist 4 is a potent agonist of THR-β. THR-β agonist 4 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021143706A1, compound 72)[1].
Related Catalog
References

[1]. Jingye Zhou, et al. Substituted triazinones as thyroid hormone receptor agonists. Patent WO2021143706A1.

 Chemical & Physical Properties

Molecular Formula C16H11Cl2F2N5O6S
Molecular Weight 510.26